Ads
related to: janssen patient assistance xarelto application"Great price transparency and cost-saving content" - Investopedia
Search results
Results from the WOW.Com Content Network
Ortho-McNeil Pharmaceutical (now operating under Janssen Pharmaceuticals) was a pharmaceutical company based in Raritan, New Jersey, that was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. [1]
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]
Antistasin, the first discovered naturally occurring direct Xa inhibitor Rivaroxaban, the first synthetic direct Xa inhibitor marketed as a drug Prior to the introduction of direct factor Xa inhibitors, vitamin K antagonists such as warfarin were the only oral anticoagulants for over 60 years, and together with heparin have been the main blood ...
Health-care giant Johnson & Johnson recently released a press statement that said that the FDA has turned down its bid to receive approval to treat patients with acute coronary syndrome (ACS) with ...
Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life-threatening conditions who do not meet the enrollment criteria for the clinical trial in progress.
Andexanet alfa, sold under the brand name Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation is needed due to uncontrolled bleeding. [8] It has not been found to be useful for other factor Xa inhibitors. [9] It is given by injection into a vein. [9]
Huawei Technologies asked a U.S. judge to dismiss much of a federal indictment accusing the Chinese telecommunications company of trying to steal technology secrets from U.S. rivals and misleading ...
The Individual Patient Assistance (IPA) has become the cornerstone of the Foundation's outreach to the public. This program targets newly diagnosed cancer patients in Los Angeles County and Orange County who are currently undergoing aggressive cancer treatment such as chemotherapy or radiation , and are experiencing financial hardship as a ...
Ads
related to: janssen patient assistance xarelto application"Great price transparency and cost-saving content" - Investopedia